Curr Opin Urol 2021 May 6. Epub 2021 May 6.
Department of Urology, Federal Armed Services Hospital Koblenz, Koblenz, Germany Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria Department of Urology, The Jikei University School of Medicine, Tokyo, Japan Research Center for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic Department of Urology, Weill Cornell Medical College, New York, New York, USA Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria Department of Urology, University of Jordan, Amman, Jordan.
Purpose Of Review: Although survival outcomes are the primary outcomes to determine the effectiveness of treatment options, quality of life (QoL) is gaining in importance in addition to classic oncological outcomes. The present review aims to state and critically assess the challenges in health-related QoL (HRQoL) assessment especially in bladder cancer (BC) patients.
Recent Findings: General QoL-instruments do not address concerns specific to cancer patients or BC patients. Read More